Yes it incorporated the
5-to-1 share consolidation

RM1.44 target price from MBSB/MIDF. It looks like a massive jump, but if you do the math, it’s actually a downgrade.

Think about it: with the 5-for-1 share consolidation coming up on June 9, their old RM0.36 target should automatically multiply to RM1.80 (0.36 x 5)

By capping it at RM1.44, the analysts are quietly slashing their valuation of the stock by 20%.

The headline number only looks bigger because our shares are being merged, but the analyst is actually less bullish than before.

0.850 小买怡情，大买养家庭！
0.845 今天下一注，明天住别墅！

Will Pharma follow SOLUTN, BINTAI and HWGB ?